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Controlling Hair Follicle Signaling Pathways through
Polyubiquitination
Erik G. Huntzicker1 and Anthony E. Oro1
Hair follicle development and maintenance require precise reciprocal signaling interactions between the
epithelium and underlying dermis. Three major developmental signaling pathways, Wnt, Sonic hedgehog, and
NF-kB/Edar, are indispensable for this process and, when aberrantly activated, can lead to skin and appendage
neoplasms. Recent data point to protein polyubiquitination as playing a central role in regulating the timing,
duration, and location of signaling. Here we review how polyubiquitination regulates the stability and
interaction of key signaling components that control hair follicle development and regeneration.
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Introduction
Despite their architectural and func-
tional diversity, epithelial organs, and
appendages, such as the vertebrate hair
follicle, lung, and prostate share com-
mon developmental strategies. Each
derives from ectodermal or endodermal
progenitors and, through the interac-
tion with the underlying mesenchyme,
is launched upon a characteristic pro-
gram of proliferation, migration, apop-
tosis, and differentiation to form a
mature organ (Gumbiner, 1992;
Chuong, 1998; Watt and Hogan,
2000; Fuchs et al., 2004; Chuong
et al., 2006). Several highly conserved
developmental signaling pathways are
crucial for appendage development
and maintenance. In the hair follicle,
the Edar/NF-kB pathway is required at
the earliest stages of hair follicle and
epidermal appendage development
(Headon and Overbeek, 1999; Botch-
karev and Fessing, 2005; Mou et al.,
2006). In a similar manner, the Wnt/b-
catenin pathway initiates morphogene-
sis and the onset of hair cycling
(Huelsken et al., 2001; Van Mater
et al., 2003). Finally, the Sonic hedge-
hog (Shh)/Gli signaling pathway drives
hair progenitor proliferation that is
required to build a growing hair follicle
(Callahan and Oro, 2001; Oro and
Higgins, 2003; Levy et al., 2005).
The essential regulatory mechani-
sms controlling the intensity and
duration of each of these signals on a cell
-by-cell basis during hair morphogen-
esis are poorly understood. Abnormal-
ities in the above pathways result in
birth defects, inflammation, or cancer
predisposition, reinforcing the need to
understand how they are controlled. An
emerging theme is the central role for
protein polyubiquitination in control-
ling the timing and location of active
morphogenic signaling. As with protein
phosphorylation, another common
post-translational modification of pro-
teins, recent studies have documented
myriad functional changes in response
to ubiquitination (Reinstein and Cie-
chanover, 2006). For instance, poly-
ubiquitination is well documented to
lead to recognition by the proteasome
and destruction of the protein (Re-
chsteiner, 1987). However, recent data
suggest that polyubiquitination can also
regulate protein–protein interactions,
leading to altered transcription factor
activity and subcellular localization
of transcriptional cofactors (Dennis
and O’Malley, 2005; Dhananjayan
et al., 2005). Finally, new experiments
suggest that monoubiquitination may
have distinct properties from polyubi-
quitination and has been associated
with vesicular trafficking of proteins dur-
ing receptor endocytosis (Mukhopadhyay
and Riezman, 2007). In this review, we
will focus on the emergence of polyubi-
quitination as a critical mechanism to
regulate key hair follicle morphogenic
and maintenance pathways.
Mechanisms of polyubiquitination
The covalent modification of proteins
with ubiquitin has been well studied
and is highly specific and strictly
controlled by three distinct protein
activities termed E1–E3 (Pickart and
Eddins, 2004). Ubiquitin is a highly
conserved 76 aa protein expressed in
all cells. Cellular ubiquitin is first
‘‘activated’’ by transfer to an E1 and
subsequently to one of numerous E2
ubiquitin ligases. Specificity of ubiqui-
tination is conferred when an E3 ligase
binds to its substrate protein, facilitat-
ing transfer of the activated ubiquitin.
The ubiquitin ligase can initiate further
rounds of ubiquitin ligation, resulting
in a ‘‘ubiquitin chain’’ of multiple
ubiquitins.
Two major types of polyubiquitin
chains have been identified based on
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which lysine in ubiquitin is used for
chain elongation (Figure 1). Multimeric
K48-linked chains of ubiquitin are
recognized by the proteasome, which
specifically degrades ubiquitinated
substrates. The proteasome is a barrel-
shaped, multi-protein complex, com-
posed of a 20S core, which houses the
highly active proteolytic sites and a 19S
‘‘lid’’ that regulates entry of ubiquiti-
nated proteins. The destruction rate of a
protein is roughly proportional to the
rate it accumulates mature poly-ubi-
quitin chains. This rate, in turn, is
determined by a competition between
the polymerization activity of the E3
ligases and the depolymerization by
deubiquitinating enzymes (DUBs).
On the other hand, multimeric
K63-linked ubiquitin chains, instead
of being efficiently shuttled to the
proteasome for destruction, facilitate
important protein–protein interactions.
Studies comparing K48 and K63 linked
proteins indicate that K63-linked ubi-
quitin-modified proteins can still be
recognized by the proteasome, but
with reduced affinity (Varadan et al.,
2004). This allows the ubiquitinated
protein to form novel protein com-
plexes not seen without the modifi-
cation (Wu et al., 2006). As with
K48-linked ubiquitin-modified proteins,
specific K63-specific DUBs. The length
of K63 ubiquitin chains is controlled
by (Brummelkamp et al., 2003;
Kovalenko et al., 2003; Trompouki
et al., 2003).
Substrate selection is a tightly regu-
lated process. Substrate binding by an
E3 ligase is a necessary precondition
for ubiquitination. The ligase binds
sequence motifs on the substrate called
degrons. As many ligases and substrates
have been characterized, it is clear that
each E3 ligase can often only recognize
a single type of degron. Further, many
degrons require post-translational
‘‘priming’’ modifications, such as phos-
phorylation, to be recognized by an E3
ligase. This priming step broadens the
opportunities for regulating the stability
of a substrate protein through the
concerted activity of multiple kinases
in different signaling pathways. In
addition, a given substrate may be
acted upon by multiple ubiquitin li-
gases (and likely DUBs), either simul-
taneously or individually in unique
biological contexts. This allows the cell
to integrate information from many
simultaneous signals to give precise
temporal and spatial control of
protein stability or activity. In the hair
follicle, many recent reports illustrate
how polyubiquitination can precisely
control hair follicle proliferation and
differentiation. Here we illustrate the
general mechanisms and abnormalities
associated with three polyubiquitin-
controlled signaling pathways in the
hair (Table 1).
Initiation of morphogenesis and cycling:
a job for Wnt/ b-catenin
One of the best examples of regulation
by polyubiquitination in the skin is the
control of b-catenin protein levels
during Wnt signaling. Numerous stu-
dies and recent reviews support a
critical role for the Wnt/b-catenin path-
way in triggering the earliest events of
anagen, the active growth phase of the
hair follicle. Continued activation of
the Wnt/b-catenin pathway maintains
follicle growth, whereas reduction in
active b-catenin leads to follicular
regression (Silva-Vargas et al., 2005).
Given the central importance of
b-catenin in Wnt signaling, the levels
and stability of this protein are tightly
regulated by several destruction path-
ways. Under most conditions, b-cate-
nin performs an integral role at
adherens junctions by acting as a
bridge between transmembrane cad-
herin proteins and the cytoskeleton via
a-catenin (Weis and Nelson, 2006).
Under non-signaling conditions, b-
catenin not associated with adherens
junctions is rapidly degraded by the
proteasome.
At least two distinct destruction
pathways control b-catenin steady state
levels. The first is the SCF (Skp1-
Cullin1-Fbox) E3 ligase consisting of
the scaffolding protein Cullin-1 (Cul1)
and the substrate-binding protein
b-TrCP (Hart et al., 1999). b-TrCP only
recognizes b-catenin that is phosphory-
lated by Glycogen synthase kinase 3b
(GSK3b) at key residues in its N-
terminal degron (Salic et al., 2000).
This phosphorylation requires the co-
operation of the scaffolding proteins
Axin and adenomatous polyposis coli
protein to bring GSK3b and b-Catenin
into close proximity (Hart et al., 1998).
The morphogen Wnt blocks b-TrCP
mediated ubiquitination via inhibition
of GSK3b and a cessation of the
ubiquitination reaction. This, in turn,
leads to the stabilization and accumu-
lation of b-Catenin, its translocation to
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Figure 1. Polyubiquitin modification and protein function. Polyubiquitination is highly specific and
often requires priming phosphorylation of the substrate to allow E3 ligase recognition and transfer of
ubiquitin. Attachment to different lysines (K48 or K63) gives different structures and results either in
recognition by the proteasome and destruction or recognition by protein complexes and signal
transduction. Specific K48 or K63 DUBs control the reverse process.
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the nucleus and activation of Wnt
target genes.
A distinct Wnt and b-TrcP-indepen-
dent destruction mechanism has
recently been identified that controls
b-catenin levels during cell-cycle reg-
ulation. In response to p53 induction,
b-catenin levels are decreased by the
proteasome using a different E3 ligase
known as seven in absentia homolog
(Liu et al., 2001; Matsuzawa and Reed,
2001). This ubiquitination event does
not require the activity of GSK3b or
Wnt, but requires an adapter protein
ebi-1. Together, seven in absentia
homolog/ebi-1 is thought to maintain
low basal levels of the substrate upon
p53 activation. Interestingly, a priming
kinase such as GSK3b has yet to be
found for ebi-1, suggesting that the
regulation of destruction complex is
mediated by transcriptional upregula-
tion of the ubiquitin ligase components
rather than post-translational modifica-
tion of the b-catenin substrate itself.
Genetic loss of key components of
the ubiquitination pathway such as
Axin or adenomatous polyposis coli or
point mutations at key degron residues
in b-Catenin are documented in spora-
dic and inherited forms of colon cancer
as well as hair follicle tumors. Strong
nuclear localization of b-catenin is also
characteristic of benign pilomatricomas
and malignant pilomatrix carcinomas.
Sequencing of b-catenin from these
hyperproliferative lesions reveals that
25–100% of benign lesions and 100%
of malignant lesions harbor stabilizing
mutations in b-catenin (Chan et al.,
1999; Kajino et al., 2001; Moreno-
Bueno et al., 2001; Lazar et al., 2005).
These point mutations disrupt the in-
tegrity of the N-terminal degron and
prevent b-catenin’s proteasome-depen-
dent degradation.
Growing the follicle: Shh/Gli regulation
Polyubiquitination also plays a critical
role in regulating the Shh/Gli pathway
during hair morphogenesis. Following
the b-catenin-dependent induction of
anagen, bulge stem cells proliferate
and expand hair follicle-specific pro-
genitor cells in the outer root sheath, a
process dependent on Shh. Inhibition
of the Shh pathway during embryonic
development arrests the follicle at the
hair bud stage after placode formation
and initial ingrowth (St-Jacques et al.,
1998). Furthermore, inhibition of Shh
in adult skin prevents anagen hair
growth (Wang et al., 2000). Shh hedge-
hog signaling is mediated in the nu-
cleus by the Gli family of transcription
factors. Three Gli family members are
present in mammals, with Gli1 and
Gli2 acting as transcriptional activators
and Gli3 acting almost exclusively as a
transcriptional repressor. The sum ac-
tivity of the activators and repressors
determines pathway output. Shh bind-
ing to its receptor patched alters the
balance of transcriptional activity away
from repression and toward transcrip-
tional activation.
Both repressor formation and acti-
vator stability intimately depend on
ubiquitination and the proteasome
(Figure 2). In the absence of Shh, Gli3
repressor formation occurs via protea-
some-dependent processing. Repressor
formation is dependent upon the con-
certed activity of at least three kinases:
protein kinase A, casein kinase Ie, and
GSK3b. Extensive sequential phosphory-
lation by these kinases on the C-
terminus of Gli3 creates an atypical
degron, which is recognized and
bound by b-TrCP (Tempe´ et al.,
2006). As in the case of b-catenin,
binding of b-TrCP leads to ubiquitina-
tion of the substrate. Unlike b-catenin,
recognition by b-TrCP does not appear
to require adenomatous polyposis coli
or Axin. Also unlike b-Catenin, Gli3 is
not fully degraded but instead is
specifically digested by the proteasome
(Wang and Li, 2006). The mechanism
of partial proteolysis is poorly under-
stood, but results in degradation of the
C-terminal activation domain to form a
Table 1. Regulating hair follicle signaling pathways by polyubiquitination
Pathway Target Kinase Linkage Ligase DUB
Disease/
phenotype Reference
NF-kB TRAF2/6 ? K63 TRAF6 CYLD Cylindromatosis Brummelkamp et al., 2003
1kB 1KK K48 b-TrCP ? Karin and Ben-Neriah, 2000
Wnt b-Catanin GSK3b K48 b-TrCP ? Pilomatricoma Chan et al., 1999
K48 Ebi1/SIAH ? Matsuzawa and Reed, 2001
K48 Smurf/Smad7 UCH37 Han et al., 2006
Hedgehog Gli3 PKA GSK3b CKI K48 b-TrCP ? Pallister–Hall Wang et al., 2000; Wang and
Li, 2006
Gli1,2 ? K48 b-TrCP ? Huntzicker et al., 2006;
Bhatai, 2006
Gli1 ? Numb/Itch ? Di Marcotullio et al., 2006
Gli2,3 ? SPOP ? Kent et al., 2006; Zhang
et al., 2006b
TGFb/BMP Smad Type 1 Receptor? K48 Smurf/Smad7 UCH37 Lo and Massague, 1999;
Kavsak et al., 2000
Notch Notch1 ? K48 Numb/Itch ? McGill and McGlade, 2003
DUB, deubiquitinating enzyme.
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potent transcriptional repressor. How-
ever, the end result is similar to Wnt/b-
catenin, as activation of the pathway by
Shh blocks substrate phosphorylation,
inhibits b-TrCP ligase binding, ubiqui-
tination, proteolysis, and repressor for-
mation. This results in the de-repression
of Shh target genes.
Although the ubiquitin-proteasome
system facilitates Gli3 repressor forma-
tion, it also effects the complete de-
gradation of the Gli1 and Gli2
activators. Gli2 appears to be phos-
phorylated in a manner very similar to
Gli3. Pharmacological or genetic in-
hibition of this C-terminal phosphory-
lation stabilizes Gli2 (Pan et al., 2006).
Gli1 lacks a full complement of phos-
phorylation sites and therefore may
not be regulated in the same way
(Huntzicker et al., 2006). However,
Gli2 and Gli1 both contain a highly
conserved degron that is independent
of the C-terminal phosphorylation sites.
This degron resembles the canonical b-
TrCP-binding site but differs by lacking
the critical second serine phosphoryla-
tion site. Despite its atypical sequence,
this motif is required to mediate bind-
ing of Gli1 and Gli2 to b-TrCP (Bhatia
et al., 2006; Huntzicker et al., 2006)
and its removal results in delayed
destruction kinetics and Gli protein
stabilization.
Recent data have identified addi-
tional regulatory pathways controlling
Gli levels Structure-function studies of
Gli1 stability led to the identification of
a highly conserved degron in the N-
terminus of Gli1, although the ligase
binding to this site was not determined
(Huntzicker et al., 2006). Further,
additional ligases that regulate Gli
levels have also been found. Data from
Drosophila suggest that the MATH
(Meprin and TRAF-C Homology)
and BTB/POZ (Bric-a-brac, Tramtrack,
Broad complex/Polio virus and Zinc
finger) domain-containing protein
Speckle type Poz Protein binds to the
fly Gli homolog cubitus interrupts (Ci)
and regulates protein levels. Speckle
type Poz Protein has been shown to
bind the N- and C-termini of Ci and has
also been shown to interact with
vertebrate Gli proteins (Kent et al.,
2006; Zhang et al., 2006b). The rela-
tionship of the degrons and the ligases
and their significance remains to be
shown.
As Shh plays a critical role in both
development and tumor formation, it is
not too surprising that alterations in
repressor and or activator stability
might have serious consequences. Con-
stitutive Gli3 repressor formation is
seen in people with a rare develop-
mental abnormality called Pallister–Hall
Syndrome. In this syndrome, the
activation domain normally removed
by the ubiquitin-proteasome system is
lost through truncating or frame-shift
mutations. This results in constitutive
repressor formation and prevents acti-
vation of the pathway, leading to limb,
neural tube, and hair follicle abnorma-
lities. In contrast to the Wnt pathway
where b-catenin mutations are rela-
tively common, mutations that stabilize
Gli1 or Gli2 have not been found in
human tumor samples, although they
are just now being examined. In animal
models of Basal cell carcinoma forma-
tion in which the Shh pathway is
activated, removal of either the b-TrCP
degron or the N-terminal conserved
region (or both) partially stabilized the
Gli1 protein relative to unmutated,
wild-type Gli1 protein. Tumors devel-
op 2–4 weeks earlier in mice expressing
mutant Gli1 than in those expressing
the wild-type protein, demonstrating
that the proteasome-dependent de-
struction of Gli1 is an important means
of controlling Shh pathway activity in
the skin (Huntzicker et al., 2006).
Differentiation with NF-jB/TRAF signaling
The NF-kB signaling pathway is a
multicomponent pathway that regu-
lates the expression of hundreds of
genes involved in many key cellular
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Figure 2. Regulation of the Gli transcription factors by polyubiquitination. Three Gli proteins transduce
the hedgehog signal. In the absence of hedgehog, the pathway repressor Gli3 is produced after
ubiquitination and cleavage by the proteasome. This process requires protein kinase A, GSK3b, Casein
kinase Ie, and the E3 ligase b-TrCP. Gli2 is also acted upon by b-TrCP and the same set of kinases, but is
fully degraded rather than cleaved by the proteasome. Both the formation of the Gli3 repressor and the
destruction of Gli2 are inhibited by Shh. Transcriptional activators Gli1 and Gli2 are degraded by a
separate pathway that is also mediated by b-TrCP. At this time, it is unclear whether this destruction
process is reversed by hedgehog addition. Several studies have also identified other E3 ligases, such as
Speckle type Poz Protein, and degrons have whose function is still unclear. These studies have suggested
a possible independent nuclear role for the proteasome in controlling Gli activator and repressor levels.
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and organismal processes, including
cell proliferation, cell survival, the
cellular stress response, innate immu-
nity, inflammation, and ectodermal
appendage differentiation. Although
NF-kB operates in numerous pathways,
in the hair follicle, it is notable for
mediating the transcriptional effects of
ectodysplasin receptor signaling during
hair morphogenesis (Botchkarev and
Fessing, 2005). As with other pathways,
polyubiquitination regulates NF-kB sig-
naling at almost every step of the signal
transduction process. Pathway activa-
tion is ultimately determined by the
translocation of heterodimeric NF-kB
transcription factors to the nucleus.
Under non-signaling conditions, this
translocation is prohibited by cytoplas-
mic sequestration of NF-kB proteins by
IkB proteins. Pathway activation results
in the phosphorylation, ubiquitination
by b-TrCP, and destruction of IkB
proteins, thus releasing NF-kB for
nuclear translocation (Karin and Ben-
Neriah, 2000; Ghosh and Karin, 2002).
Overexpression of constitutively ac-
tive forms of NF-kB leads to cell-cycle
arrest in keratinocytes and epidermal
hypoplasia. Conversely, overexpres-
sion of non-destructable IkB results in
NF-kB inactivation, subsequent hyper-
plasia, and sensitivity to Ras-induced
neoplasia (Dajee et al., 2003). The
kinase complex responsible for initia-
ting phosphorylation of the IkB proteins
is itself regulated by ubiquitination.
Assembly of the kinase complex re-
quires the auto-ubiquitination of the
tumor necrosis factor-a receptor asso-
ciated factor 6 (TRAF6). This ubiquiti-
nation results in the formation of K63
poly-ubiquitin chains. These poly-ubi-
quitin chains, as opposed to K48 chains
do not lead to proteasome-dependent
destruction. This auto-ubiquitination of
TRAF6 is opposed by the action of the
DUB CYLD, whose activity is inhibited
upon pathway activation. Loss of
CYLD leads to constitutive pathway
activation, characterized by constitu-
tive nuclear localization of NF-kB
proteins (Brummelkamp et al., 2003;
Kovalenko et al., 2003; Trompouki
et al., 2003). Paradoxically, instead of
leading to keratinocyte cell-cycle arrest
and epidermal hypoplasia, genetic
loss of CYLD in humans results in a
predisposition to developing cylindro-
mas and other tumors of hair-follicle
origin (Bignell et al., 2000; Takahashi
et al., 2000). This phenotype cannot be
reproduced in mice; however, genetic
loss of TRAF6 and upstream signaling
components of the Edar-signaling path-
way leads to the loss of certain hair
types (Cui et al., 2003). Similar muta-
tions in humans lead to multiple
defects in all ectodermal appendages.
Future directions
In this review, we have highlighted
recent advances in our understanding
of how polyubiquitinated proteins con-
tribute to three critical pathways during
hair follicle morphogenesis. Recent
data suggest polyubiquitination plays
a much broader role in regulating
protein function than was previously
thought. In addition to simple destruc-
tion by the proteasome, polyubiquiti-
nation can have several effects
including partial proteolysis of func-
tional domains, activation, and scaf-
folding for the association of protein
complexes. Further, with the identifica-
tion of monoubiquitination in the
trafficking of receptors, the functional
role of protein ubiquitination in signal-
ing has gained great importance.
This review focuses on E3 ligases
that polymerize the ubiquitin chain.
However, intense experimentation is
now focused on identifying the various
classes of DUBs, the enzymes that
depolymerize ubiquitin chains. In other
tissues, critical roles for removing
ubiquitin chains have been documen-
ted for the DNA damage response
(Zhang et al., 2006a), proliferation,
and apoptosis (Li et al., 2005). Closer
examination of the functions of these
proteins may reveal key functions in
regulating hair morphogenic signaling.
The inherent modularity of protein
destruction pathways suggests the op-
portunity for coordinate regulation. As
seen in Table 1, GSK3b priming and b-
TrCP binding are shared between the
Shh and Wnt pathways. This suggests
the intriguing possibility of the ability to
regulate b-catenin and Gli3 processing
simply by regulating GSK3b activity, b-
TrCP levels, or DUB activity. Examples
from other signaling pathways not
mentioned here include the E3 ligase
Itch-Numb that, while previously
shown to ubiquitinate the hair differ-
entiation regulator Notch (McGill and
McGlade, 2003), now appears to also
control levels of the Gli proteins (Di
Marcotullio et al., 2006). Similarly,
Smurf2, previously shown to regulate
the BMP pathway in complex with
Smad7 (Lo and Massague, 1999; Kav-
sak et al., 2000), also appears to
regulate b-catenin levels (Han et al.,
2006). These results suggest that ex-
ternal signals such as cell-cycle regula-
tion or growth factors may coordinately
regulate the stability or interaction of
several pathways.
Appendage progenitor cells must
make minute-to-minute developmental
decisions in order to faithfully replicate
a particular organ. Previous studies
with protein phosphorylation have re-
vealed a host of functions that can be
regulated. The study of other modifica-
tions, including polyubiquitination,
acetylation, and methylation, are just
in their infancy, but are likely to
illuminate how the pathways control-
ling hair follicle morphogenesis can be
tightly regulated.
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